Because of a lapse in government funding, the information on this website may not be up to date transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit

Updates regarding government operating status and resumption of normal operations can be found at


  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
 (... beh-vuh-SIH-zoo-mab)

This page contains brief information about the drug combination called FOLFIRI-BEVACIZUMAB. The drugs in the combination are listed, and links to individual drug summaries are included.

FDA Approval for Bevacizumab

Drugs in the FOLFIRI-BEVACIZUMAB combination:
FOL = Leucovorin Calcium (Folinic Acid)
F = Fluorouracil
IRI = Irinotecan Hydrochloride
+ Bevacizumab

Chemotherapy is often given as a combination of drugs. Combinations usually work better than single drugs because different drugs kill cancer cells in different ways.

Each of the drugs in this combination is approved by the Food and Drug Administration (FDA) to treat cancer or conditions related to cancer.

Use in Cancer

FOLFIRI-BEVACIZUMAB is used to treat:

This combination may also be used with other drugs or treatments or to treat other types of cancer.


Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

  • Posted: August 16, 2011
  • Updated: February 13, 2013